Moderna and Generation Bio Announce Collaboration To Develop Non-Viral Genetic Medicines;Generation Bio To Receive $40M Upfront Cash Payment, Prepayment Of Research Funding Plus $36M Equity Investment From Moderna
Moderna and Generation Bio Announce Collaboration To Develop Non-Viral Genetic Medicines;Generation Bio To Receive $40M Upfront Cash Payment, Prepayment Of Research Funding Plus $36M Equity Investment From Moderna
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.